181 related articles for article (PubMed ID: 22020697)
21. Intralesional cidofovir for recurrent respiratory papillomatosis in children.
Pransky SM; Magit AE; Kearns DB; Kang DR; Duncan NO
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1143-8. PubMed ID: 10522508
[TBL] [Abstract][Full Text] [Related]
22. Urrets-Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment.
Orssaud C; Wermert D; Roux A; Laccourreye O; Sors H; Roche O; Dufier JL
Eye (Lond); 2014 Jun; 28(6):776-7. PubMed ID: 24675584
[No Abstract] [Full Text] [Related]
23. Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
Donne A; Rothera M; Homer J
Clin Otolaryngol; 2010 Feb; 35(1):60. PubMed ID: 20447168
[No Abstract] [Full Text] [Related]
24. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
Broekema FI; Dikkers FG
Eur Arch Otorhinolaryngol; 2008 Aug; 265(8):871-9. PubMed ID: 18458927
[TBL] [Abstract][Full Text] [Related]
25. Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
Lott DG; Krakovitz PR
Laryngoscope; 2009 Mar; 119(3):567-70. PubMed ID: 19235765
[TBL] [Abstract][Full Text] [Related]
26. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
[TBL] [Abstract][Full Text] [Related]
27. Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Rivière F; Gille T; Le Tinier JY; Gharbi N; Khalil A; Wislez M; Cadranel J
Scand J Infect Dis; 2011 Feb; 43(2):112-4. PubMed ID: 21039305
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir.
Pransky SM; Albright JT; Magit AE
Laryngoscope; 2003 Sep; 113(9):1583-7. PubMed ID: 12972938
[TBL] [Abstract][Full Text] [Related]
29. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Donne AJ; Rothera MP; Homer JJ
Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
[TBL] [Abstract][Full Text] [Related]
30. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
31. Use of cidofovir for treatment of recurrent respiratory papillomatosis.
Derkay C
Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):198-201. PubMed ID: 19221249
[No Abstract] [Full Text] [Related]
32. Laryngeal papilloma.
DeFatta RA; Sataloff JB; Klaris GE; Sataloff RT
Ear Nose Throat J; 2012 May; 91(5):E21-2. PubMed ID: 22614564
[No Abstract] [Full Text] [Related]
33. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].
Snoeck R; Wellens W; Desloovere C; Van Ranst M; Naesens L; De Clercq E; Feenstra L
J Med Virol; 1998 Mar; 54(3):219-25. PubMed ID: 9515772
[TBL] [Abstract][Full Text] [Related]
34. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.
Pransky SM; Brewster DF; Magit AE; Kearns DB
Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1239-43. PubMed ID: 11031411
[TBL] [Abstract][Full Text] [Related]
35. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
36. Gilead issues new warnings about cidofovir nephrotoxicity.
Am J Health Syst Pharm; 1997 Jan; 54(1):12, 15. PubMed ID: 9117780
[No Abstract] [Full Text] [Related]
37. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
[No Abstract] [Full Text] [Related]
38. Use of cidofovir in recurrent respiratory papillomatosis.
Carifi M
Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):2165-6. PubMed ID: 23545883
[No Abstract] [Full Text] [Related]
39. Cidofovir: to use or not to use?
Soma MA; Albert DM
Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029
[TBL] [Abstract][Full Text] [Related]
40. Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis.
de Bilderling G; Bodart E; Lawson G; Tuerlinckx D; Remacle M; Naesens L; De Clercq E; Snoeck R
J Med Virol; 2005 Feb; 75(2):332-5. PubMed ID: 15602729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
